2seventy bio Completes Spin Transaction and Launches Innovative Immuno-oncology Cell Therapy Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. DFTX
9. HOOD
10. IBM

Go back to 2seventy bio Completes Spin Transaction and Launches Innovative Immuno-oncology Cell Therapy Company

Criteo S.A. (CRTO) PT Raised to $58 at BMO Capital

November 5, 2021 6:44 AM EDT

BMO Capital analyst Daniel Salmon raised the price target on Criteo S.A. (NASDAQ: CRTO) to $58.00 (from $52.00) while maintaining an Outperform rating.

The analyst commented, "The tone around Retail Media remains upbeat, with emphasis on CRTO being the #1 independent platform in the category.... More